<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240311061254N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-04-14</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of saffron extract on sex hormones and sexual dysfunction in opioid-dependent men undergoing maintenance treatment with methadone, opium tincture and voluntary withdrawal</public_title>
      <acronym>عصاره زعفران- ختلال عملکرد جنسی-متادون، تنتور اوپیوم - ترک اختیاری</acronym>
      <scientific_title>Effect of saffron (Crocus sativus L.) extract on oxidative stress, sex hormones and sexual dysfunction in opioid-dependent men undergoing methadone, opium tincture maintenance treatment and voluntary abstinence</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>240</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75964</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Basic scienece, Other design features: Investigating the sexual dysfunction of opioid-dependent patients that saffron extract can improve sexual function and improve the quality of their sexual life, Randomization description: There are 30 people in each group (180 people in total). With an estimate of 25% attrition, we first include 40 people in each group who are eligible to enter the study. Because the work will be done in several stages, we will use the information of the initial stages to estimate the exact sample size and continue the study until reaching that number of samples, and they will be divided into two groups using blocks of four.</study_design>
      <phase>3</phase>
      <hc_freetext>Opioid dependent men undergoing maintenance treatment with methadone, opium tincture and voluntary withdrawal.</hc_freetext>
      <i_freetext>Intervention group: Intervention group: under maintenance treatment with methadone and opium ventor and voluntary withdrawal who are taking saffron extract tablets..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Miladi Georgi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Five kilometers from Damghan Road - Semnan Medical School</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 912 531 3069</telephone>
        <email>miladi331@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein Miladi Georgi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Five kilometers from Damghan Road - Semnan Medical School</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3513138111</zip>
        <telephone>+98 912 531 3069</telephone>
        <email>miladi331@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The entry of married men knowingly, without coercion and freely, who are literate and literate, will participate in this study by filling and signing a written consent form, and they are psychologically and cognitively healthy, aware and alert. Active use of opioid substances for at least 5 years before the study and people receiving methadone or opium tincture have been under maintenance treatment with methadone or opium tincture for at least 1 year. According to the sexual disorders questionnaire, have sexual problems with a minimum score (average). Patients' evaluation: all the relevant information will be available in accordance with the ethical principles in maintaining and trusting the identity of the patients. 1- Personal characteristics: name, surname, father's name, ID number, place of birth, date of birth 2- Basic demographic characteristics: gender, marital status, level of education, occupation, weight, height, level of physical activity, race (native or not) 3- The type of narcotic used by the patients 4- Determining the dosage and duration of the narcotic in the past months 5- Examining the previous treatment history of the patients in the field of addiction, including outpatient methods, hospitalization, self-medication, staying in camps and camps etc. 6- History of sexual problems, including late or early ejaculation, dysfunction of erectile function, decreased sexual desire, sexual behavior problems, general dissatisfaction with sexual relations 7- History of prison 8- History of physical and special diseases</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>50 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>All patients who have severe anxiety, depression, stress, mental disorders (suicidal thoughts and withdrawal, dementia, autism, mental retardation, psychosis, bipolar disease, etc.) and have cardiovascular, kidney, liver, lung, thyroid, diabetes, Gastrointestinal diseases, blood pressure, all types of cancer and infectious diseases and AIDS, and they also have drug sensitivity, plant allergies, autoimmune diseases, sexual problems and congenital reproductive system, and taking medicine is harmful for them. They have absolute prohibition conditions.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: under maintenance treatment with methadone and opium ventor and voluntary withdrawal who are taking saffron extract tablets.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Investigation of saffron extract on sexual dysfunction in opioid-dependent men undergoing maintenance treatment with methadone, opium tincture and voluntary withdrawal. Timepoint: Before the intervention of saffron tablets and 1 day after taking the last dose, questionnaires will be filled, sperm sampling and blood sampling will be done to determine the evaluation of the desired parameters. After the statistical analysis of the data in the relevant groups, if the saffron extract is effective after 1 month to ensure the durability of the effect of saffron on sexual function, the sexual disorders questionnaire will be completed by the patients in the form of follow-up and support. Method of measurement: Investigation of sexual disorders based on questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Investigating saffron extract on oxidative stress, sex hormones, sperm parameters and craving intensity in opioid dependent men undergoing maintenance treatment with methadone, opium tincture and voluntary withdrawal. Timepoint: Before the intervention of saffron tablets and 1 day after taking the last dose, questionnaires, sperm sampling and blood sampling of patients will be done to determine the evaluation of the desired parameters. After the statistical analysis of the data in the relevant groups, if the saffron extract is effective after 1 month to ensure the durability of the effect of saffron on sexual function, the sexual disorders questionnaire will be completed by the patients in the form of follow-up and support. Method of measurement: Investigating oxidative stress, sex hormones through blood sampling and sperm samples through marital relationships and severity of addiction and craving based on questionnaires.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-12</approval_date>
        <contact_name>IR.SEMUMS.REC</contact_name>
        <contact_address>Five kilometers from Damghan road - Semnan University of Medical Sciences Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
